Oops! Something went wrong while submitting the form.
Services
Hormonal change at midlife is not a single event with a single answer. Perimenopause begins years before periods stop and produces a wide range of symptoms that often do not match what the person has read or been told to expect. Menopause brings further hormonal change and a new long-term physiological context. For some people, hormone replacement therapy is the right tool inside that transition. For others, it is not. For many, the answer changes over time — the right approach at 45 is not the right approach at 60.
Hormone replacement therapy in this pathway is the specialist work of getting that picture right. The clinician — a nurse practitioner with experience in women's hormones — works with what the symptom picture, the bloodwork, the personal and family medical history and the person's goals all indicate. Bioidentical and conventional HRT, transdermal and oral, oestrogen, progesterone and testosterone, are all options inside the conversation. The aim is the right hormonal support, at the right dose, for the right duration, with the right monitoring.
This service is for adults navigating perimenopause, menopause, low testosterone, surgical menopause, or other hormonal transitions where pharmacological support is being considered. It is also for people on existing HRT whose current regime is not producing the change it should, and who need a careful review.
The first appointment reads the picture as it currently sits. Symptom mapping, cycle history where relevant, menopausal stage, prior hormonal contraception, prior HRT or hormonal trials, family history (breast, ovarian, cardiovascular, thrombotic), current medications and current quality of life.
Where bloodwork or other investigation will change the management, that is named and arranged — appropriate timing for sex hormones, full thyroid panel, lipid and metabolic markers, other markers as indicated. Where the picture is already clear from symptoms and history, the investigation is matched accordingly.
The HRT plan is built around the person. Choice of hormones — oestrogen, progesterone, testosterone — and route (oral, transdermal, vaginal) are matched to the picture. Bioidentical and conventional options are discussed openly, including what is known and unknown about each. Dose is started carefully, with planned titration.
The plan is built with the rest of the biio. team in view. Where dysautonomia, mast-cell, mental-health or other parts of the broader picture are active, those are read into the plan. Where shared care with the patient's GP or specialist gynaecologist is the structure, that is named.
Each HRT trial has a review point. Symptoms tracked, side-effects tracked, bloodwork where relevant. Doses, formulations and routes are adjusted against what the body did, not against what was expected.
HRT is not necessarily lifelong, and not necessarily short. Where ongoing therapy is appropriate, the dose finds the minimum effective level and stays there. Where therapy was a bridge through a transition, it is tapered as the transition completes.
When the HRT work is going well, the symptoms that brought the person to the consultation ease without the picture being destabilised in other directions. Sleep returns. Hot flushes and night sweats reduce. Mood, energy and cognition stabilise. Sexual function and intimate-life quality can improve where those were part of the picture. Bone-health and cardiovascular risks are managed where HRT plays a role in that.
HRT is one tool. It does not change the broader transition the person is moving through, and it does not by itself address every part of the menopausal picture. What it can do, where clinically indicated, is take one set of symptoms out of the daily picture so the rest of the work — sleep, nutrition, movement, mental health — has somewhere to land.